Welcome to LookChem.com Sign In|Join Free
  • or
DIMETHYL PYRAZINE-2,5-DICARBOXYLATE is an organic compound that serves as a crucial reactant in the synthesis of various biologically active agents. It is characterized by its unique chemical structure, which allows it to participate in multiple chemical reactions and contribute to the formation of complex molecules with potential applications in the pharmaceutical industry.

13051-89-3

Post Buying Request

13051-89-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13051-89-3 Usage

Uses

Used in Pharmaceutical Industry:
DIMETHYL PYRAZINE-2,5-DICARBOXYLATE is used as a reactant for the synthesis of biologically active agents, specifically proteasome inhibitors for the treatment of multiple myeloma. These inhibitors play a vital role in disrupting the cellular processes that contribute to the growth and survival of cancer cells, thereby providing a potential therapeutic approach to combat multiple myeloma.
Additionally, DIMETHYL PYRAZINE-2,5-DICARBOXYLATE is used as a reactant in the synthesis of pyrazinyl and pyridinyl bis(oxazoline) ligands. These ligands are essential components in the preparation of (R)-Verapamil (V124990), a calcium channel blocker with applications in the treatment of various cardiovascular conditions, such as hypertension, angina, and arrhythmias.

Check Digit Verification of cas no

The CAS Registry Mumber 13051-89-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,0,5 and 1 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 13051-89:
(7*1)+(6*3)+(5*0)+(4*5)+(3*1)+(2*8)+(1*9)=73
73 % 10 = 3
So 13051-89-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H8N2O4/c1-13-7(11)5-3-10-6(4-9-5)8(12)14-2/h3-4H,1-2H3

13051-89-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name DIMETHYL PYRAZINE-2,5-DICARBOXYLATE

1.2 Other means of identification

Product number -
Other names 2,5-Pyrazindicarbonsaeure-dimethylester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13051-89-3 SDS

13051-89-3Relevant academic research and scientific papers

Synthesis and reactivity of a 1,4-dihydropyrazine derivative

Rodrigues, Anabela,Ferreira, Paula M.T.,Monteiro, Luís S.

, p. 8489 - 8496 (2004)

N,N-Bis-(tert-butoxycarbonyl)-2,5-bis-methoxycarbonyl-1,4-dihydropyrazine can be obtained in high yield by treatment of the methyl ester of N-(4-toluenesulfonyl)-N-(tert-butoxycarbonyl)-α,β-didehydroalanine with dimethylaminopyridine and potassium carbona

TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING A PYRIDINE OR PYRAZINE MOIETY, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR

-

Paragraph 0137, (2019/02/28)

Compounds having a structure according to formula (I) where R1 and Ar are as defined herein, are agonists for the Toll-like receptor 7 (TLR7) and can be used as adjuvants for stimulating the immune system. Some such compounds can be used in conjugates for targeted delivery to the organ or tissue of intended action.

Self-Assembly of Cyclohelicate [M3L3] Triangles Over [M4L4] Squares, Despite Near-Linear Bis-terdentate L and Octahedral M

Hogue, Ross W.,Dhers, Sébastien,Hellyer, Ryan M.,Luo, Jingwei,Hanan, Garry S.,Larsen, David S.,Garden, Anna L.,Brooker, Sally

supporting information, p. 14193 - 14199 (2017/10/07)

Self-assembly of 1:1:2 MII(BF4)2 (M=Zn or Fe), pyrazine-2,5-dicarbaldehyde (1) and 2-(2-aminoethyl)pyridine gave trimetallic triangle architectures rather than the anticipated tetrametallic [2×2] squares. Options for the n

DOPAMINE D3 RECEPTOR ANTAGONISTS COMPOUNDS

-

Page/Page column 126, (2016/05/19)

The disclosure is directed to novel dopamine D3 receptor antagonists, processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them and their use in therapy, including treating drug dependency and psychosis.

Quaternary Stereogenic Centers through Enantioselective Heck Arylation of Acyclic Olefins with Aryldiazonium Salts: Application in a Concise Synthesis of (R)-Verapamil

Oliveira, Caio C.,Pfaltz, Andreas,Correia, Carlos Roque Duarte

supporting information, p. 14036 - 14039 (2016/01/25)

We describe herein a highly regio- and enantioselective Pd-catalyzed Heck arylation of unactivated trisubstituted acyclic olefins to provide all-carbon quaternary stereogenic centers. Chiral N,N ligands of the pyrimidine- and pyrazino-oxazoline class were developed for that purpose, providing the desired products in good to high yields with enantiomeric ratios up to >99:1. Both linear and branched substituents on the olefins were well-tolerated. The potential of this new method is demonstrated by the straightforward synthesis of several O-methyl lactols and lactones containing quaternary stereocenters, together with a concise enantioselective total synthesis of the calcium channel blocker verapamil.

Design, synthesis, and biological evaluation of bone-targeted proteasome inhibitors for multiple myeloma

Agyin, Joseph K.,Santhamma, Bindu,Roy, Sudipa S.

supporting information, p. 6455 - 6458 (2013/11/19)

Multiple myeloma (MM) is an incurable neoplasm characterized by devastating and progressive bone destruction. Standard chemotherapeutic agents have not been effective at significantly prolonging the survival of MM patients and these agents are typically a

Dinuclear copper(II) complexes of two homologous pyrazine-based bis(terdentate) diamide ligands

Klingele, Julia,Moubaraki, Boujemaa,Murray, Keith S.,Boas, John F.,Brooker, Sally

, p. 1530 - 1541 (2007/10/03)

The 1:1 reactions of the new bis(terdentate) diamide ligand N, N′-bis(2-pyridylmethyl)pyrazine-2,5-dicarboxamide (H2L 1) and its higher homologue N,N′-bis[2-(2-pyridyl)ethyl] pyrazine-2,5-dicarboxamide (H2L2) with Cu(BF 4)2·4H2O in the absence of added base have consistently afforded dicopper(II) complexes of the doubly deprotonated ligands (L1)2- and (L2)2-. The complex [CuII2(L2)(H2O) 2(MeCN)2](BF4)2 (2a) has been structurally characterised. Subsequently, reactions employing a correct stoichiometric 2:1 metal-to-ligand ratio in MeCN have afforded bulk samples of the dinuclear complexes. The compounds [CuII2(L 1)(MeCN)2(H2O)2)(BF 4)2·H2O (1a·H2O) and [CuII2(L2)(H2O)4(BF 4)2]-2H2O (2b-2H2O) have been structurally characterised. While complex 1a-H2O of the lower ligand homologue exhibits very weak antiferromagnetic spin coupling (J = -0.24 cm -1), complex 2b of the higher ligand homologue exhibits very weak ferromagnetic spin coupling (J = +0.67 cm-1). EPR studies have been carried out on polycrystalline powders and frozen DMF solutions of 1a-H 2O and 2b·2H2O. The EPR spectra of the polycrystalline powders indicate the presence of dipolar broadening and weak intermolecular exchange, while those of the frozen DMF solutions are characteristic of dipolar-coupled CuII pairs within the dinuclear molecules, with no evidence of intraor intermolecular exchange. The spectral simulations confirm that the binuclear structure and the Cu...Cu distances are retained in frozen solution. Dinuclear SiF22- containing compounds, [CuII2(L1)(H2O) 4](SiF6) (1b) and [[CuII2(L 1)(H2O)2(μSiF6))·4H 2O]∞ (1c-4H2O). were obtained serendipitously, in nearly quantitative yield, by the 2:1 reaction of Cu(BF 4)2· 4H2O with H2L 1 in H2O. The unexpected SiF62- anions were generated in the course of the reaction by partial hydrolysis of the BF4- anions employed, thus forming traces of HF which reacted with the glassware.

Stereoisomeric tricyclic bis(dioxopiperazines) and pharmaceutical compositions

-

, (2008/06/13)

Stereoisomeric tricyclic bis(dioxopiperazines) of the formula STR1 wherein R is H or STR2 and the processes for the synthesis thereof are provided. The compounds are effective as antitumor or antimetastatic drugs.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 13051-89-3